ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,757, issued on Aug. 19, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).
"Bispecific antibodies specific for PD1 and TIM3" was invented by Laura Codarri-Deak (Schlieren, Switzerland), Georg Fertig (Penzberg, Germany), Jens Fischer (Penzberg, Germany), Christian Klein (Schlieren, Switzerland), Viktor Levitski (Schlieren, Switzerland), Valeria Lifke (Penzberg, Germany), Mario Perro (Schlieren, Switzerland), Joerg Thomas Regula (Penzberg, Germany), Tilman Schlothauer (Basel, Germany), Stefan Seeber (Penzberg, Germany), Pablo Umana (Penzberg, Switzerland), Ildiko Wuensche (Penzberg, Germany) and Adrian Zwick (Penzberg, Germany).
According to the abstract* released by the ...